NovoSeven HI 1 mg syringe for intravenous injection

NovoSeven HI 1 mg syringe for intravenous injection (YJ code: 6343434D6020, 1 mg 1 mL x 1 bottle (with dissolving solution)), manufactured by Novo Nordisk Pharma, contains Polyethylene glycol-treated human anti-tetanus immunoglobulin, though NovoSeven is generally known to contain eptacog alfa (activated). NovoSeven is indicated for the treatment of bleeding episodes and prevention of bleeding during surgery in patients with congenital hemophilia with inhibitors, acquired he…